| CBBZX | VIVAX | CBBZX / VIVAX | |
| Total Expense Ratio | 0.62 | 0.17 | 365% |
| Annual Report Gross Expense Ratio | 0.63 | 0.17 | 371% |
| Fund Existence | 13 years | 34 years | - |
| Gain YTD | 17.195 | 16.369 | 105% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.92B | 262B | 1% |
| Annual Yield % from dividends | 0.93 | 1.70 | 55% |
| Returns for 1 year | 14.16 | 19.52 | 73% |
| Returns for 3 years | 27.77 | 55.69 | 50% |
| Returns for 5 years | 17.51 | 60.68 | 29% |
| Returns for 10 years | 55.82 | 160.50 | 35% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SHE | 157.93 | 1.71 | +1.09% |
| Stt Strt® SPDR® MSCI USA Gndr Divst ETF | |||
| CANQ | 29.71 | 0.24 | +0.81% |
| Calamos Nasdaq® Equity & Income ETF | |||
| IVOV | 112.25 | 0.87 | +0.78% |
| Vanguard S&P Mid-Cap 400 Value ETF | |||
| CHAU | 20.76 | N/A | N/A |
| Direxion Dly CSI 300 CHN A Shr Bl 2X ETF | |||
| FMCE | 28.50 | -0.06 | -0.22% |
| FM Compounders Equity ETF | |||